Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy
ABSTRACT Background Emerging studies indicate that microbes are present in tumor cells and immune cells. Intratumoral microbiota (ITM) constitute an important component of the tumor immune microenvironment (TIME) and have an important impact on tumor progression and treatment. Objective Through the general elaboration of ITM represented by bacteria and
Fengxue Li +13 more
wiley +1 more source
Phage Therapy for <i>Acinetobacter baumannii</i> Infections: A Review on Advances in Classification, Applications, and Translational Roadblocks. [PDF]
Wang Y, Li L, Liang Y, Xu K, Ye Y, He M.
europepmc +1 more source
Should Phage Therapy Be Approved in the U.S.
Benjamin James Cossette +2 more
openalex +1 more source
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms
Ashlan J. Kunz Coyne +5 more
openalex +1 more source
Beyond bacterial defences: the role of lysozyme in cancer
Lysozyme (LYZ) is a multi‐functional secreted factor that encompasses both antibacterial and immunomodulatory functions. Emerging evidence highlights its complex role in tumour progression by directly influencing tumour cells and modulating the immune microenvironment.
Lei Wang +4 more
wiley +1 more source
Phage Therapy for Hospital-Acquired Respiratory Bacterial Infections: A Review. [PDF]
Muñoz-Egea MC +3 more
europepmc +1 more source
Efficacy of phage therapy in controlling staphylococcal biofilms: a systematic review. [PDF]
Mobarezi Z +3 more
europepmc +1 more source
Mechanism of action of the intestinal microbiota on CNS autoimmune diseases. Environmental factors shape gut microbiota composition; dysbiosis alters microbial metabolites and antigenic signals. These modulate innate and adaptive immunity, affect barrier integrity, and influence CNS‐resident cells such as microglia and astrocytes, contributing to ...
Matteo Ceccon, Francesca Ronchi
wiley +1 more source
Evolving strategies of intracellular Hypervirulent <i>Klebsiella pneumoniae</i> during phage therapy: Reducing host autophagy and inflammation. [PDF]
Chen H +7 more
europepmc +1 more source

